Viva Biotech Holdings (FRA:VB0) Inventory Turnover: 1.78 (As of Dec. 2025)

What is Viva Biotech Holdings Inventory Turnover?

Viva Biotech Holdings FRA:VB0 43 Inventory Turnover is 1.78 as of Dec. 2025. GuruFocus rates FRA:VB0 with a GF Score™ of 43/100 and a GF Value™ of €0.08 (Significantly Overvalued). The stock has 5 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Viva Biotech Holdings's Cost of Goods Sold for the six months ended in Dec. 2025 was €70.5 Mil. Viva Biotech Holdings's Average Total Inventories for the quarter that ended in Dec. 2025 was €39.5 Mil. Viva Biotech Holdings's Inventory Turnover for the quarter that ended in Dec. 2025 was 1.78.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Viva Biotech Holdings's Days Inventory for the six months ended in Dec. 2025 was 102.24.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Viva Biotech Holdings's Inventory-to-Revenue for the quarter that ended in Dec. 2025 was 0.36.

Viva Biotech Holdings (FRA:VB0) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Viva Biotech Holdings's Days Inventory for the six months ended in Dec. 2025 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2025 )	/	Cost of Goods Sold (Q: Dec. 2025 )	*	Days in Period
	=	39.497	/	70.5	*	365 / 2
	=	102.24

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Viva Biotech Holdings's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	39.497	/	108.832
	=	0.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Viva Biotech Holdings Inventory Turnover Related Terms

Viva Biotech Holdings Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Viva Biotech Holdings's Inventory Turnover can be seen below:

Viva Biotech Holdings Inventory Turnover Chart

Viva Biotech Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

7.63

5.55

4.70

4.93

3.41

Viva Biotech Holdings Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24	Jun25	Dec25
Inventory Turnover	Get a 7-Day Free Trial													2.53	2.47	2.41	1.61	1.78

43GF Score

Viva Biotech Holdings FRA:VB0

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Viva Biotech Holdings Inventory Turnover Calculation

Viva Biotech Holdings's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	130.21	/ (	(35.77	+	40.709)	/	2 )
=	130.21	/	38.2395
=	3.41

Viva Biotech Holdings's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

	Inventory Turnover (Q: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Dec. 2025 )	/ (	(Total Inventories (Q: Jun. 2025 )	+	Total Inventories (Q: Dec. 2025 ))	/	count )
=	70.5	/ (	(38.285	+	40.709)	/	2 )
=	70.5	/	39.497
=	1.78

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 1.78 mean?

Viva Biotech Holdings (FRA:VB0) has a Inventory Turnover of 1.78 as of Dec. 2025. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Viva Biotech Holdings and its competitors.

Is Viva Biotech Holdings' Inventory Turnover too high?

Viva Biotech Holdings' current Inventory Turnover is 1.78. Overall, Viva Biotech Holdings has a GF Score™ of 43/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Viva Biotech Holdings' Inventory Turnover compare to VRTX and REGN?

Viva Biotech Holdings' Inventory Turnover of 1.78 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Biotechnology company?

A good Inventory Turnover depends on the Biotechnology industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Viva Biotech Holdings and its competitors. Viva Biotech Holdings's current Inventory Turnover is 1.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Viva Biotech Holdings stock overvalued right now?

Based on GuruFocus' analysis, Viva Biotech Holdings (FRA:VB0) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.08, compared to a current price of €0.12 — trading 53.8% above its estimated fair value. The current Inventory Turnover is 1.78. Viva Biotech Holdings' overall GF Score™ is 43/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Viva Biotech Holdings (FRA:VB0), the current Inventory Turnover is 1.78 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Viva Biotech Holdings (FRA:VB0) Overvalued in 2026?

Based on GuruFocus' analysis, Viva Biotech Holdings stock appears to be overvalued. The current stock price of €0.12 is trading 53.8% above its estimated GF Value™ of €0.08. GuruFocus considers Viva Biotech Holdings to be Significantly Overvalued.

Key valuation signals for FRA:VB0:

Inventory Turnover: 1.78
GF Value™: €0.08 vs. price of €0.12 (53.8% above fair value)
GF Score™: 43/100 with 5 warning signs

No single metric tells the full story. See the FRA:VB0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Viva Biotech Holdings Business Description

Industry Healthcare Biotechnology

Comparable Companies HKSE:02565 HKSE:02197 HKSE:02410 HKSE:06996 HKSE:01875 HKSE:02480 HKSE:06660 HKSE:01521 HKSE:06955 HKSE:02181 VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges VBIZF:USA 01873:Hong Kong

Address 735 Ziping Road, Pudong New District, Zhoupu Town, Shanghai, CHN, 201318

Website https://www.vivabiotech.com

Viva Biotech Holdings is engaged in providing the structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development. The company operates in three reportable segments, Drug Discovery Services providing structure-based drug discovery services to biotechnology and pharmaceutical customers for their pre-clinical stage drug development; Contract Development Manufacture Organisation providing contract development and manufacturing services for small molecule APIs and intermediates and trading of APIs, intermediates and formulations; and commercialisation services; and Viva BioInnovator making strategic investments in biotechnology startup companies.

43GF Score

Get the complete analysis for FRA:VB0

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.12

Price

€0.08

GF Value

View FRA:VB0 Analysis

See Inventory Turnover data for all stocks →